Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
Hosokawa S, Ichihara E, Harada D, Kuyama S, Inoue K, Gemba K, Ichikawa H, Kato Y, Oda N, Oze I, Tamura T, Kozuki T, Umeno T, Kubo T, Hotta K, Bessho A, Maeda Y, Kiura K. Hosokawa S, et al. Among authors: gemba k. Int J Clin Oncol. 2022 Jul;27(7):1139-1144. doi: 10.1007/s10147-022-02164-2. Epub 2022 May 10. Int J Clin Oncol. 2022. PMID: 35534642 Clinical Trial.
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients.
Takigawa N, Segawa Y, Kishino D, Fujiwara K, Tokuda Y, Seki N, Shinkai T, Watanabe Y, Hiraki S, Kozuki T, Gemba K, Tabata M, Kiura K, Ueoka H, Tanimoto M. Takigawa N, et al. Among authors: gemba k. Cancer Chemother Pharmacol. 2004 Sep;54(3):230-6. doi: 10.1007/s00280-004-0826-x. Epub 2004 May 4. Cancer Chemother Pharmacol. 2004. PMID: 15127232 Clinical Trial.
Hypercalcemia-leukocytosis syndrome associated with lung cancer.
Hiraki A, Ueoka H, Takata I, Gemba K, Bessho A, Segawa Y, Kiura K, Eguchi K, Yoneda T, Tanimoto M, Harada M. Hiraki A, et al. Among authors: gemba k. Lung Cancer. 2004 Mar;43(3):301-7. doi: 10.1016/j.lungcan.2003.09.006. Lung Cancer. 2004. PMID: 15165088
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group.
Hotta K, Kiura K, Tabata M, Harita S, Gemba K, Yonei T, Bessho A, Maeda T, Moritaka T, Shibayama T, Matsuo K, Kato K, Kanehiro A, Tanimoto Y, Matsuo K, Ueoka H, Tanimoto M. Hotta K, et al. Among authors: gemba k. Cancer J. 2005 Sep-Oct;11(5):417-24. doi: 10.1097/00130404-200509000-00010. Cancer J. 2005. PMID: 16259873
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
Tabata M, Kozuki T, Ueoka H, Kiura K, Harita S, Tada A, Shibayama T, Takigawa N, Yonei T, Gemba K, Segawa Y, Kishino D, Tada S, Hiraki S, Tanimoto M; Okayama Lung Cancer Study Group. Tabata M, et al. Among authors: gemba k. Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. doi: 10.1007/s00280-006-0346-y. Epub 2006 Sep 29. Cancer Chemother Pharmacol. 2007. PMID: 17009034 Clinical Trial.
87 results